Given their important role in CMML pathogenesis (62), such epigenetic alterations could account for the decreased expression of CXCL8 receptors on CMML CD34+ cells, in contrast with other myeloid malignancies (39, 63). This evidence concerns the gene CD34 and myeloid neoplasm.